Key facts
- This page summarizes Forest Baskett's Form 5 filing for Trevi Therapeutics, Inc. (TRVI).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 13 Feb 2026, 16:30.
Key filing fact
Ownership activity is grounded in SEC Form 5 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Exercise of in-the-money or at-the-money derivative security
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Exercise of in-the-money or at-the-money derivative security
Additional SEC filing notes
Footnote F1
The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 16 securities in which the Reporting Person has no pecuniary interest.